Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study

被引：0
|
作者：
Shoko Marshall
Takeru Wakatsuki
Daisuke Takahari
Tomohiro Matsushima
Naoki Ishizuka
Izuma Nakayama
Hiroki Osumi
Mariko Ogura
Takashi Ichimura
Eiji Shinozaki
Keisho Chin
Kensei Yamaguchi
机构：
[1] Tokyo Women’s Medical University Medical Center East,Department of Medicine
[2] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Gastrointestinal Oncology
[3] Saitama Cancer Center,Department of Gastroenterology
[4] Department of Clinical Trial Planning and Management,undefined
[5] Clinical Research & Medical Development Center,undefined
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
HER2; Gastric cancer; Trastuzumab; Prognostic factor; Visceral metastasis; Low hemoglobin; High LDH; High CRP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 484
页数：9
相关论文
共 50 条
  • [21] Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
    Jun Zhou
    Zhi Peng
    Yi Liu
    Jifang Gong
    Xiaotian Zhang
    Ming Lu
    Jing Gao
    Yili Li
    Yanyan Li
    Lin Shen
    Journal of Gastroenterology, 2015, 50 : 955 - 961
  • [22] Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
    Zhou, Jun
    Peng, Zhi
    Liu, Yi
    Gong, Jifang
    Zhang, Xiaotian
    Lu, Ming
    Gao, Jing
    Li, Yili
    Li, Yanyan
    Shen, Lin
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 955 - 961
  • [23] Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy
    Hayano, Koichi
    Watanabe, Hiroki
    Ryuzaki, Takahiro
    Sawada, Naoto
    Ohira, Gaku
    Kano, Masayuki
    Uesato, Masaya
    Matsubara, Hisahiro
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [24] Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy
    Koichi Hayano
    Hiroki Watanabe
    Takahiro Ryuzaki
    Naoto Sawada
    Gaku Ohira
    Masayuki Kano
    Masaya Uesato
    Hisahiro Matsubara
    Surgical Case Reports, 6
  • [25] Successful Use of Trastuzumab with Anthracycline-based Chemotherapy Followed by Trastuzumab Maintenance in Patients with Advanced HER2-positive Gastric Cancer
    Palacio, Sofia
    Loaiza-Bonilla, Arturo
    Kittaneh, Muaiad
    Kyriakopoulos, Christos
    Ochoa, Roberto E.
    Escobar, Mauricio
    Arango, Belisario
    Restrepo, Maria H.
    Merchan, Jaime R.
    Lima, Caio M. S. Rocha
    Hosein, Peter J.
    ANTICANCER RESEARCH, 2014, 34 (1A) : 301 - 306
  • [26] HER2DX ERBB2 mRNA assay following trastuzumab-based chemotherapy in HER2-positive (HER2+) advanced gastric cancer (AGC)
    Sauri Nadal, T.
    Pesantez Coronel, D. S.
    Braso Maristany, F.
    Indacochea, A.
    Cuatrecasas, M.
    Sanfeliu Torres, E.
    Lopezprades, S.
    Candia, L.
    Fernandez-Esparrach, G.
    Mendez, I.
    Nogue Aliguer, M.
    Momblan, D.
    Angelats, L.
    Pascual, T.
    Prat, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S194 - S194
  • [27] A Review of Trastuzumab-Based Therapy in Patients with HER2-positive Metastatic Breast Cancer
    Church, David N.
    Price, Chris G. A.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 557 - 570
  • [28] Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
    Jun Zhou
    Zhi Peng
    Yi Liu
    Jifang Gong
    Xiaotian Zhang
    Ming Lu
    Jing Gao
    Yili Li
    Yanyan Li
    Lin Shen
    Journal of Gastroenterology, 2016, 51 : 509 - 510
  • [29] Comparison of HER2 Status Before and After Trastuzumab-based Chemotherapy in Patients With Advanced Gastric Cancer
    Kijima, Takashi
    Arigami, Takaaki
    Uenosono, Yoshikazu
    Hiraki, Tsubasa
    Yanagita, Shigehiro
    Matsushita, Daisuke
    Okubo, Keishi
    Shimonosono, Masataka
    Ishigami, Sumiya
    Maemura, Kosei
    Tanimoto, Akihide
    Natsugoe, Shoji
    ANTICANCER RESEARCH, 2020, 40 (01) : 75 - 80
  • [30] Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
    Tae-Hwan Kim
    Hun Do Cho
    Yong Won Choi
    Hyun Woo Lee
    Seok Yun Kang
    Geum Sook Jeong
    Jin-Hyuk Choi
    Mi Sun Ahn
    Seung-Soo Sheen
    BMC Cancer, 21
12345